Armistice Capital’s Eastman Chemical EMN Stock Holding History

Armistice Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,530	Closed	-$916K	–	407
2025 Q3	$916K	Buy	+14,530	New	+$1.01M	0.01%	171

Other funds holding EMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Armistice Capital's EMN Position: Q4 2025 in Review

Armistice Capital sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 14,530 shares — an estimated $916K sold.

Armistice Capital first reported a position in EMN in Q3 2025 and held it in 1 quarter. The position peaked at $916K in Q3 2025. 633 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

Armistice Capital reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
Armistice Capital sold 14,530 Eastman Chemical shares in Q4 2025, an estimated $916K.
Armistice Capital first reported a position in Eastman Chemical in Q3 2025 and held it in 1 quarter.
Armistice Capital's Eastman Chemical position peaked at $916K in Q3 2025.
633 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.